Patents by Inventor Massimo Maria D'Amato

Massimo Maria D'Amato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Silibinin component for the treatment of hepatitis
    Patent number: 9248115
    Abstract: The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load. The medicament preferably contains no silidianin and/or no silichristin and/or no isosilibinin.
    Type: Grant
    Filed: April 26, 2013
    Date of Patent: February 2, 2016
    Assignee: MADAUS GMBH
    Inventors: Lucio Claudio Rovati, Massimo Maria D'Amato, Ulrich Mengs, Ralf-Torsten Pohl, Peter Ferenci
  • Combination andolast/glucocorticoids
    Patent number: 8809306
    Abstract: The invention relates to the combination of Andolast, a calcium-activated potassium channel opener and glucocorticoids for the treatment of patients suffering for airway diseases. Pharmaceutical compositions comprising Andoalst and glucocorticoids are also disclosed.
    Type: Grant
    Filed: July 31, 2006
    Date of Patent: August 19, 2014
    Assignee: Rottapharm S.p.A.
    Inventors: Francesco Makovec, Massimo Maria D'Amato, Antonio Giordani, Lucio Claudio Rovati
  • SILIBININ COMPONENT FOR THE TREATMENT OF HEPATITIS
    Publication number: 20130236420
    Abstract: The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load. The medicament preferably contains no silidianin and/or no silichristin and/or no isosilibinin.
    Type: Application
    Filed: April 26, 2013
    Publication date: September 12, 2013
    Applicant: MADAUS GmbH
    Inventors: LUCIO CLAUDIO ROVATI, MASSIMO MARIA D'AMATO, ULRICH MENGS, RALF-TORSTEN POHL, PETER FERENCI
  • SILIBININ COMPONENT FOR THE TREATMENT OF HEPATITIS
    Publication number: 20110182858
    Abstract: The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load.
    Type: Application
    Filed: November 14, 2008
    Publication date: July 28, 2011
    Applicant: Madaus GmbH
    Inventors: Lucio Claudio Rovati, Massimo Maria D' Amato, Ulrich Dr. Mengs, Ralf-Torsten Dr. Pohl, Peter, Dr Ferenci
  • DELOXIGLUMIDE AND PROTON PUMP INHIBITORS COMBINATION IN THE TREATMENT OF GASTROINTESTINAL DISORDERS
    Publication number: 20110065797
    Abstract: Cholecystokinin-1 (CCK1) receptor antagonists and the combination of CCK1 receptor antagonists and proton pump inhibitors (PPI) for the treatment of patients suffering from gastrointestinal or related disorders that have failed to completely respond to conventional acid suppression therapy.
    Type: Application
    Filed: November 19, 2010
    Publication date: March 17, 2011
    Applicant: ROTTAPHARM S.P.A
    Inventors: Francesco MAKOVEC, Massimo Maria D'AMATO, Antonio GIORDANI, Lucio Claudio ROVATI
  • Combination of Itriglumide and Proton Pump Inhibitors in the Treatment of Gastrointestinal and Related Disorders
    Publication number: 20110045033
    Abstract: The invention relates to the combination of the cholecystokinin-2 (CCK-2) receptor antagonist Itriglumide and proton pump inhibitors (PPIs) for the treatment of patients suffering from gastrointestinal and related disorders.
    Type: Application
    Filed: November 1, 2010
    Publication date: February 24, 2011
    Applicant: ROTTAPHARM S.p.A.
    Inventors: Lucio Claudio ROVATI, Gianfranco CASELLI, Massimo Maria D'AMATO, Antonio GIORDANI, Francesco MAKOVEC
  • Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
    Patent number: 7863330
    Abstract: Combination of dexloxiglumide and a proton pump inhibitor (PPI) for the treatment of patients suffering from functional dyspepsia and gastroesophageal reflux disease (GERD) is disclosed.
    Type: Grant
    Filed: June 14, 2006
    Date of Patent: January 4, 2011
    Assignee: Rottapharm S.p.A.
    Inventors: Francesco Makovec, Massimo Maria D'Amato, Antonio Giordani, Lucio Claudio Rovati
  • Method of relieving symptoms of gastroesophageal reflux disease
    Patent number: 7846921
    Abstract: The invention relates to a method for relieving or ameliorating symptoms of gastroesophageal reflux disease by administering a medicament that includes the cholecystokin-2 (CCK-2) receptor antagonist itriglumide and a proton pump inhibitor (PPI).
    Type: Grant
    Filed: July 24, 2006
    Date of Patent: December 7, 2010
    Assignee: Rottapharm, S.p.A.
    Inventors: Lucio Claudio Rovati, Gianfranco Caselli, Massimo Maria D'Amato, Antonio Giordani, Francesco Makovec
  • COMBINATION ANDOLAST/GLUCOCORTICOIDS
    Publication number: 20090253664
    Abstract: The invention relates to the combination of Andolast, a calcium-activated potassium channel opener and glucocorticoids for the treatment of patients suffering for airway diseases. Pharmaceutical compositions comprising Andoalst and glucocorticoids are also disclosed.
    Type: Application
    Filed: July 31, 2006
    Publication date: October 8, 2009
    Inventors: Francesco Makovec, Massimo Maria D'Amato, Antonio Giordani, Lucio Claudio Rovati
  • Benzamidine Derivatives for Treatment and Prevention of Cancer Therapy Induced Mucositis
    Publication number: 20080194877
    Abstract: Mucositis is the result of a complex process of interactive biologic phenomena that take place in both the epitelium and the submucosa, often leading to severe pain and increased risk of dangerous syste f48 mic infections. Mucositis is often a side effect during chemotherapy and radiation therapy. The benzamidine derivatives herein described are particularly effective for treating and preventing mucositis since they are acting simultaneously at the several phases that characterize this disease.
    Type: Application
    Filed: March 16, 2006
    Publication date: August 14, 2008
    Applicant: ROTTAPHARM S.p.A.
    Inventors: Ornella Letari, Massimo Maria D'Amato, Simona Zanzola, Roberto Artusi, Lucio Claudio Rovati, Gianfranco Caselli, Antonio Giordani
  • CHOLECYSTOKININ-1(CCK1) RECEPTOR ANTAGONISTS IN THE TREATMENT OF GASTROINTESTINAL AND RELATED DISORDERS
    Publication number: 20070293574
    Abstract: Cholecystokinin-1 (CCK1) receptor antagonists and the combination of CCK1 receptor antagonists and proton pump inhibitors (PPI) for the treatment of patients suffering from gastrointestinal or related disorders that have failed to completely respond to conventional acid suppression therapy.
    Type: Application
    Filed: June 14, 2006
    Publication date: December 20, 2007
    Applicant: ROTTAPHARM S.p.A.
    Inventors: Francesco MAKOVEC, Massimo Maria D'Amato, Antonio Giordani, Lucio Claudio Rovati